John Kriesel is an Infectious Disease physician affiliated with University of Utah. OpenAlex indexes 60 publications with 1,279 citations (h-index 21).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
50 N Medical Dr
Salt Lake City, UT 841320001
Telephone
801-585-2031Provider last certified this registry record 17 Nov 2021.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ABBVIE INC.Program year20251 payment
- Merck Sharp & Dohme LLCProgram year20241 payment
- ABBVIE INC.Program year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
60.5%Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor15.5%Isentress52%Tivicay48%Part D<11 patientsOther antibacterials11.5%Methenamine Hippurate100%Part D<11 patients+ 6 more classes in this area
Cardiovascular
13.9%Statin8.4%Atorvastatin Calcium100%Part D<11 patientsACE inhibitor5.4%Lisinopril100%Part D<11 patientsNervous system
10.1%Aminoketone5.7%Bupropion Xl100%Part D<11 patientsSSRI4.4%Sertraline Hcl100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
6 NIH research awards on record, funded 1997–2019 per NIH RePORTER. The latest:
- STI and Respiratory Pathogen testing in nontraditional settings
Biofire Defense, Llc.
FY2012$885,081U01AI082482
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Spinal fluid antibody profile against bacteria demonstrates intrathecal antibody production in demyelinating diseases
Journal of Molecular Medicine
2026 - Spinal fluid IgG antibodies from patients with demyelinating diseases bind multiple sclerosis-associated bacteria
Journal of Molecular Medicine
2021 - 1201. Sarcoidosis Candidate Microbes Identified by Next Generation Sequencing
Open Forum Infectious Diseases
2020
Similar KOLs
Other experts from the same institution or the same specialty.
Frederick Welt, MD
University of Utah
Jennifer Majersik, MD
University of Utah
Richard Gurgel, MD
University of Utah
Fuad Shihab, MD
University of Utah
Thomas Walsh, MD
Cornell University
Vance Fowler, MD
Duke University
Myron Cohen, MD
University of North Carolina at Chapel Hill School of Medicine
Derrick W. Crook
John Radcliffe Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”